Navigation Links
Savient Pharmaceuticals Appoints Experienced Pharmaceutical Executive, David Veitch as President of Savient Europe
Date:1/13/2012

EAST BRUNSWICK, N.J., Jan. 13, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced the appointment of David Veitch as President of Savient Europe, effective January 16, 2012.  Mr. Veitch brings extensive commercial knowledge of the European Union across marketing, sales, market access and general management and has over 24 years of pharmaceutical industry experience.  Mr. Veitch will report directly to Mr. John H. Johnson, Chief Executive Officer and President of Savient and will be responsible for establishing, building and leading Savient's European regional organization to launch and drive the future growth of KRYSTEXXA®. 

"I am pleased to welcome David to the Savient team as head of our European operations," said Mr. Johnson.  "David has spent more than twenty years in critical pharmaceutical leadership positions within the European markets and has a track record of successfully launching specialty products in Europe.  David will be a critical member of our team as we launch KRYSTEXXA in Europe and achieve our goal of bringing relief to patients suffering from refractory chronic gout in Europe, where there are currently no EMA approved treatments for refractory chronic gout available.  We believe there is a clear unmet need for new therapies to treat patients suffering from this debilitating disease and expect KRYSTEXXA will have an important role in the future management of refractory chronic gout globally."

As previously announced, in May 2011 Savient submitted its European Marketing Authorization Application (MAA) for KRYSTEXXA, and anticipates European Union approval in the second half of 2012.  The Company expects KRYSTEXXA to be available in the European Union on a named patient basis by the end of the first quarter of 2012.  Savient has engaged regional medical scientists for i
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA®
2. Savient Pharmaceuticals to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
3. Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
4. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
5. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
6. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
7. Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer
8. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
9. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
10. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
11. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... WESTPORT, Conn., March 2, 2015  Compass Diversified Holdings ... the "Company"), an owner of leading middle market businesses, ... and twelve months ended December 31, 2014. ... Available for Distribution and Reinvestment ("CAD" or "Cash Flow") ... and $58.0 million for the full year 2014;  ...
(Date:3/2/2015)... GERMANTOWN, Md., March 2, 2015  Intrexon Corporation ... synthetic biology, today announced its fourth quarter and ... Business Highlights and Recent Developments: , Acquired ... a new frontier in cellular therapeutics and other ... molecular engineering of food-grade microbes ( Lactococcus lactis ...
(Date:3/2/2015)... Biomedical, Inc., a leading processor of human tissue, synthetics, ... it hired Lou Barnes as President and ... formed UMTB Biomedical as a wholly-owned subsidiary to acquire ... 2014. UMTB is the oldest tissue bank in the ... veteran of the tissue banking industry, having most recently ...
Breaking Medicine Technology:Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 2Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 3Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 4Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 5Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 6Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 7Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 8Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 9Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 10Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 11Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 12Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 13Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 14Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 15Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 3Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 4Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 6Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 7Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 8Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 9Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 10Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 11Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 12Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 13Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 14Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 15Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 16Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 17Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 18Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 19Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 20Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 21Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 22
... 15 Tolerx, Inc., a,biopharmaceutical company engaged in ... treatment of immune-mediated diseases, announced today,the successful completion ... a novel,humanized anti-CD4 monoclonal antibody (MAb), in subjects ... study was designed to,assess the safety, tolerability, and ...
... System Runs ,Heart Model of the Future, ... To Insight, SUNNYVALE, Calif., Jan. 15 In the quest ... Montreal (UdM) have run the largest mathematical simulation of a heart,ever ... system from SGI (Nasdaq: SGIC ). The new UdM model ...
Cached Medicine Technology:Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus 2Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus 3Universite de Montreal Researchers Simulate World's Largest Heart Model Using SGI Technology 2Universite de Montreal Researchers Simulate World's Largest Heart Model Using SGI Technology 3Universite de Montreal Researchers Simulate World's Largest Heart Model Using SGI Technology 4
(Date:3/2/2015)... 02, 2015 ZoomCare announced today ... American healthcare. Zoom will expand its Portland on-demand ... and advanced care studios delivering urgent care, primary ... specialty care and outpatient surgery. With its new ... almost all healthcare needs outside of hospitalization. , ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 After a ... processes, customer service, pricing and long-term strategy, Blood Centers ... vendor of choice for member centers’ testing needs. , ... and represents more than 30 percent of the U.S. ... meeting. , “BCA is committed to drive cost savings ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 The Workgroup ... authority on the use of health IT to create ... paper, “ICD-10 Testing for Small Providers.” The white paper ... a starting point for ICD-10 testing by focusing on ... to ensure compliance with the October 1, 2015 implementation ...
(Date:3/2/2015)... The minimally invasive surgical instruments market is expected ... reach $14,133.0 million by 2019 from $10,526.2 million ... of minimally invasive surgeries over traditional open surgeries, ... and increasing number of surgical procedures among the ... surgical instruments market. , For More Details @ ...
(Date:3/2/2015)... Dinner preparation and meal planning ... success of DinnerDork , a company that ... for thousands of busy customers. The company recently ... to offer a total of 6 diverse meal ... classic recipes and comfort foods; Paleo Palette, which ...
Breaking Medicine News(10 mins):Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 3Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 3
... to Market New Imaging SystemPOWAY, Calif., March 26 ... a leading provider of medical diagnostic imaging products and ... while driving positive healthcare economics, today announced that it ... Drug Administration (FDA), enabling the Company to market and ...
... Your Critical Risk Across Network and Endpoint Assets , ... ... facing a growing and rapidly evolving set of security threats including ... and the growing number of data breaches. To help organizations stay ...
... Veterans. , ... Sherman Oaks, CA (PRWEB) March 25, ... (P.T.S.D.) dilemma. One-fifth of troops are reporting PTSD, however, current stringent ... veterans pinpoint the stressor that triggered their PTSD, even if they ...
... provider of clinical supply chain management solutions to the health ... Group, a firm specializing in medical supply chain management, as their ... ... Fairfield, Connecticut (PRWEB) March 26, 2009-- Management Health ...
... In order to expand the range and reach of its affiliate ... Network this February. This is in addition to the company,s already ... ... Diego, CA (PRWEB) March 26, 2009 -- In order to expand ...
... drugs, such as olanzapine (Zyprexa), risperidone (Risperdal) and ... disorders like schizophrenia, but also bipolar disorder and ... Unfortunately, the weight gain commonly experienced with antipsychotic ... patients, and causes many patients to discontinue their ...
Cached Medicine News:Health News:Digirad Receives 510(k) for Cardius X-ACT Rapid Cardiac SPECT/VCT Imager 2Health News:Digirad Receives 510(k) for Cardius X-ACT Rapid Cardiac SPECT/VCT Imager 3Health News:Lumension Unveils Optimal Security Podcast Series on iTunes 2Health News:Lumension Unveils Optimal Security Podcast Series on iTunes 3Health News:The Release Technique, a Solution to Helping Veterans Suffering Post Traumatic Stress Disorder 2Health News:The Release Technique, a Solution to Helping Veterans Suffering Post Traumatic Stress Disorder 3Health News:Management Health Solutions, Inc. Selects NCI Consulting Group as Dedicated Representative to IDN's and GPO's 2Health News:TestCountry.com Expands Its Affiliate Reach with Google Affiliate Network 2Health News:TestCountry.com Expands Its Affiliate Reach with Google Affiliate Network 3Health News:Combating weight gain caused by antipsychotic treatments 2
... a broad selection of tip styles ... of ophthalmic procedures. Each single use ... a safety cap to lock switch ... not in use, and carries a ...
... a broad selection of tip styles ... of ophthalmic procedures. Each single use ... a safety cap to lock switch ... not in use, and carries a ...
... The Luminary LASIK Light Probes provide ... that allows the corneal interface to be ... use of the Tindal effect and light ... of interface debris, epithelial deposits, flap edge ...
... system allows you access to the most ... system includes 10 different optotypes, crowding bars, ... characters. Random character sequencing eliminates memorization. In ... line and multiple line selection capability. The ...
Medicine Products: